Chief Executive, Zealand Pharma
Appears in 1 story
Last updated Sep 21, 2026
As of September 2026: Pursuing a global commercialization partner for glepaglutide
Zealand Pharma's Zeydovio is one step from market in Europe. On September 17, the European Medicines Agency's scientific committee recommended approving the twice-weekly injection for adults with short bowel syndrome.
Updated Sep 20
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
